BioSyent Inc.
RX.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 18.18% | 11.99% | 7.27% | 10.83% | 13.36% |
| Total Depreciation and Amortization | 239.69% | 191.17% | 198.14% | 176.13% | -32.10% |
| Total Amortization of Deferred Charges | -91.09% | -57.88% | -96.78% | -99.42% | 352.24% |
| Total Other Non-Cash Items | 130.26% | 127.90% | 119.02% | 76.93% | -609.55% |
| Change in Net Operating Assets | -1,456.38% | 165.43% | -488.12% | 160.62% | -112.31% |
| Cash from Operations | 19.19% | 359.72% | -3.42% | 67.72% | 1.66% |
| Capital Expenditure | 14.61% | -21.75% | -13.67% | 6.85% | -312.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 123.07% | -136.57% | 1,573.49% | 333.26% | 412.68% |
| Cash from Investing | 70.67% | -154.10% | 1,623.66% | 260.20% | 343.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.92% | -5.44% | -5.45% | -5.29% | -5.24% |
| Issuance of Common Stock | 68.54% | 164.25% | 361.73% | 274.29% | -- |
| Repurchase of Common Stock | -71.49% | -42.09% | -14.40% | -55.75% | 16.56% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.02% | -5.34% | -5.07% | -7.10% | -5.05% |
| Other Financing Activities | 15.91% | 15.16% | 14.48% | 13.45% | 12.87% |
| Cash from Financing | -37.00% | -21.27% | -4.56% | -32.38% | 11.39% |
| Foreign Exchange rate Adjustments | 116.79% | 96.32% | 106.68% | 115.29% | -253.23% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 22.96% | -11.90% | 480.67% | 2,577.84% | 105.92% |